PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cancer and chemobrain: Cancer diagnosis affects cognitive function

2015-04-17
(Press-News.org) Breast cancer patients often display mild cognitive defects even before the initiation of chemotherapy. A new study by Ludwig-Maximilians-Universitaet (LMU) in Munich researchers now attributes the syndrome to post-traumatic stress induced by diagnosis of the disease.

A large number of studies have shown that cancer patients very often exhibit mild deficits of attention, memory and other basic cognitive functions. The phenomenon has generally been attributed to putative side-effects of chemotherapeutic drugs on the brain, and the condition is therefore popularly referred to as chemobrain. - However, more recent investigations have detected symptoms of chemobrain in patients who had not yet embarked on a course of chemotherapy. Now a research team led by LMU's Dr. Kerstin Hermelink at the Breast Center in the Department of Gynecology and Obstetrics at Munich University Hospital has shown that, in breast cancer patients, pretreatment cognitive impairment is most probably due to posttraumatic stress induced by diagnosis of the malignancy itself. The group's findings have just appeared in the Journal of the National Cancer Institute.

Much of the published evidence for the appearance of pretreatment perturbations of cognitive function has come from studies on breast cancer patients, and several hypotheses have been advanced to account for these findings. For example, it has been proposed that malignant disease might itself disrupt certain brain functions by activating the secretion of cytokines that modulate the immune system. An alternative suggestion is based on the idea that cancer and cognitive impairment might have a common genetic basis. The latest data come from a multicenter study called Cognicares (Cognition in Breast Cancer Patients - the Impact of Cancer-related Stress), in which the LMU researchers have tested a quite different theory, for which their findings now provide strong support.

Diagnosis-associated trauma

"Cancer patients can perceive and experience their condition as a severe trauma. Indeed, many of them develop symptoms of post-traumatic stress disorder, particularly in the early phase after they receive the diagnosis," says Kerstin Hermelink. "Stress has a very considerable influence on cognitive performance and definitely impacts on brain function - so it was quite natural for us to ask whether the cognitive deficiencies displayed by many breast cancer patients might not be attributable to the stress that is inevitably associated with malignant disease."

Hermelink and her colleagues studied 166 women who had been diagnosed with breast cancer and 60 others in whom screening of the breast had revealed no signs of disease. The participants were assessed at three times during the first year following the diagnosis. Prior to the first course of treatment, the patients and the healthy controls exhibited very similar levels of performance on standard cognitive tests. However, in one specific test of attention, members of the patient group had a significantly higher error rate. "And as we suspected at the outset, the higher failure rate in this test could be linked to post-traumatic stress - the greater the level of stress, the more errors they made, and statistical analysis confirmed that the correlation was highly significant," as Kerstin Hermelink explains.

Some good news too

Interestingly, the extent of pretreatment cognitive impairment detected in the Cognicares study was considerably lower than that reported in several earlier investigations. "This is probably because we took great pains to control effectively for the possible impact of factors that could have distorted the interpretation of the results," says Hermelink. "In particular, we made sure that differences in the composition of the two groups were minimized as far as possible." This is important because even slight differences in age structure, level of education or intelligence between the patients and the control group can result in discrepancies in cognitive performance on standardized tests, which could mask - or amplify - the extent of cognitive impairment displayed by the patients.

"For breast cancer patients our findings are good news," says Kerstin Hermelink. "At all events - in pretreatment phase at least - they give no grounds for the belief that such patients suffer from more than minimal cognitive deficiencies, which are induced by the stress associated with the disease itself."

The Cognicares study is one of the most extensive investigations of its kind yet carried out anywhere in the world. Six breast cancer centers located in and around Munich participated in the project, which was made possible by a grant from the Deutsche Krebshilfe (the German Cancer Aid). The results of the tests undertaken after the termination of primary treatment are now being analyzed.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Droperidol is safe for agitated ER patients, despite black box warning

2015-04-17
WASHINGTON --Droperidol is safe and effective for calming violent and aggressive emergency patients, and the negative effects that garnered a black box warning from the Food and Drug Administration (FDA) are actually quite rare. A new study of the once ubiquitous, now scarce, sedating agent was published online Wednesday in Annals of Emergency Medicine ("The Safety and Effectiveness of Droperidol for Sedation of Acute Behavioral Disturbance in the Emergency Department"). "In our study, the two side effects that led to the black box warning - QT prolongation and torsades ...

NEJM editorial: New studies about endovascular therapy for stroke represent paradigm shift

2015-04-17
CLEVELAND -- Anthony J. Furlan, MD, Chairman of Neurology and Co-Director of the Neurological Institute at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine, who writes an accompanying editorial for five studies about endovascular stroke therapy published simultaneously in the New England Journal of Medicine (NEJM.org April 17), says these randomized clinical trials represent a breakthrough in showing the benefits of endovascular therapy for acute ischemic strokes. "Now even endovascular skeptics will be convinced," Dr. ...

Engineer improves rechargeable batteries with MoS2 nano 'sandwich'

Engineer improves rechargeable batteries with MoS2 nano sandwich
2015-04-17
MANHATTAN, KANSAS -- The key to better cellphones and other rechargeable electronics may be in tiny "sandwiches" made of nanosheets, according to mechanical engineering research from Kansas State University. Gurpreet Singh, assistant professor of mechanical and nuclear engineering, and his research team are improving rechargeable lithium-ion batteries. The team has focused on the lithium cycling of molybdenum disulfide, or MoS2, sheets, which Singh describes as a "sandwich" of one molybdenum atom between two sulfur atoms. In the latest research, the team has found ...

UCLA demographer produces best estimate yet of Cambodia's death toll under Pol Pot

2015-04-17
The death toll in Cambodia under Khmer Rouge leader Pol Pot was most likely between 1.2 million and 2.8 million -- or between 13 percent and 30 percent of the country's population at the time -- according to a forthcoming article by a UCLA demographer. April 17 is the 40th anniversary of the Khmer Rouge's capture of the capital of Cambodia -- beginning a four-year period that many consider to be a genocide. For decades, researchers have sought to pinpoint the death toll from political executions, disease, starvation and forced labor inflicted under the Khmer Rouge. Conventional ...

Self-affirmations may calm jitters and boost performance, research finds

2015-04-17
When the stakes are high, people in positions of low power may perform better by using self-affirmations to boost their confidence, according to new research published by the Society for Personality and Social Psychology. "Most people have experienced a time in their lives when they aren't performing up to their potential. They take a test or have a performance review at work, but something holds them back," says lead researcher Sonia Kang, Ph.D. "Performance in these situations is closely related to how we are expected to behave." The researchers conducted three experiments ...

Smokers underestimate risks of a few cigarettes

2015-04-17
Geneva, Switzerland, 17 April 2015 -- Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day, despite decades of public health campaigning, French researchers have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland. The results demonstrate powerfully that the war against smoking is far from over, says oncologist Dr Laurent Greillier from Hopital Nord in Marseille, France, who presented the results at the conference. Greillier and colleagues analysed data from a representative survey ...

Should they stay or go? Study finds no harm when hospitals allow familes to observe CPR

2015-04-17
ANN ARBOR, Mich. -- When a hospital patient's heart stops, the drama starts, as doctors and nurses work furiously at resuscitation. And at many hospitals, that's the cue for someone to pull a curtain and hurry the patient's loved ones out of the room. But some hospitals allow those family members to stay, and watch the cardiopulmonary resuscitation (CPR) and other attempts to save the patient's life that the medical team makes. Now, a study has shown for the first time on a national scale that patients do just as well after a cardiac arrest at those hospitals, compared ...

Trial co-led by Pitt expert shows better function after stroke if clots removed

2015-04-17
PITTSBURGH, April 17, 2015 - A technique that removes blood clots from large brain blood vessels reduced disability after stroke in a trial conducted in Catalonia, Spain, and co-led by an expert from the University of Pittsburgh School of Medicine. The findings will be announced today at the annual meeting of the European Stroke Organisation in Glasgow, Scotland, and published online in the New England Journal of Medicine. The results of the trial, known as REVASCAT, echo findings from other recent large studies that were stopped early when the technique, called endovascular ...

Young women objectify themselves more browsing Facebook and magazines than media types

2015-04-17
Los Angeles, CA (April 17, 2015) Though it is widely believed that the media objectifies women, women further diminish themselves by constantly comparing their bodies to others'. Regardless of how much time young women devote to viewing television, music videos and using the internet, they will compare their appearances more frequently to photos in magazines and on Facebook, finds a new paper published today in Psychology of Women Quarterly. "Our research shows that spending more time reading magazines and on Facebook is associated with greater self-objectification among ...

A game-changer for stroke treatment

2015-04-17
Stroke is the leading cause of severe long-term disability in the United States, and less than 40 percent of patients who experience the most severe form of stroke regain functional independence if they receive the standard drug intervention alone. Now a study by an international group of stroke physician-researchers has found that removal of the clot causing a severe stroke, in combination with the standard medication, improves the restoration of blood flow to the brain and may result in better long term outcomes. The findings of the Swift Prime trial (Solitaire With ...

LAST 30 PRESS RELEASES:

Students who use dating apps take more risks with their sexual health

Breakthrough idea for CCU technology commercialization from 'carbon cycle of the earth'

Keck Hospital of USC earns an ‘A’ Hospital Safety Grade from The Leapfrog Group

Depression research pioneer Dr. Philip Gold maps disease's full-body impact

Rapid growth of global wildland-urban interface associated with wildfire risk, study shows

Generation of rat offspring from ovarian oocytes by Cross-species transplantation

Duke-NUS scientists develop novel plug-and-play test to evaluate T cell immunotherapy effectiveness

Compound metalens achieves distortion-free imaging with wide field of view

Age on the molecular level: showing changes through proteins

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

Slow editing of protein blueprints leads to cell death

[Press-News.org] Cancer and chemobrain: Cancer diagnosis affects cognitive function